US2021363199A1PendingUtilityA1
Method for soluble expression and purification of hydrophobin
Assignee: UNIV NAT CHONNAM IND FOUNDPriority: May 20, 2020Filed: Jul 30, 2020Published: Nov 25, 2021
Est. expiryMay 20, 2040(~13.8 yrs left)· nominal 20-yr term from priority
C07K 14/37C07K 1/36C12N 15/70C07K 2319/20C12N 15/62C07K 2319/02C07K 2319/00C07K 7/06
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of expressing hydrophobin in a soluble form and a method of purifying hydrophobin, and more particularly, to a method of expressing a recombinant fusion protein including hydrophobin in a soluble form in a host cell and then purifying the expressed recombinant fusion protein are provided.
Claims
exact text as granted — not AI-modified1 . A recombinant fusion protein expressed in a soluble form, comprising:
a target protein; and a ramp tag for controlling a translation rate, fused at an N-terminal of the target protein, wherein a signal sequence of the N-terminal of the target protein is subjected to mutation.
2 . The recombinant fusion protein of claim 1 , wherein the target protein is hydrophobin.
3 . The recombinant fusion protein of claim 2 , wherein the target protein is a Class I hydrophobin.
4 . The recombinant fusion protein of claim 3 , wherein the target protein is DewA.
5 . The recombinant fusion protein of claim 1 , wherein a wild type target protein consists of an amino acid sequence of SEQ ID NO: 2.
6 . The recombinant fusion protein of claim 1 , wherein the target protein consists of an amino acid sequence of SEQ ID NO: 8 or 10.
7 . The recombinant fusion protein of claim 1 , wherein the ramp tag consists of an amino acid sequence of SEQ ID NO: 5.
8 . The recombinant fusion protein of claim 1 , wherein the signal sequence consists of a base sequence of SEQ ID NO: 3.
9 . The recombinant fusion protein of claim 1 , wherein the mutation is one or two or more selected from the group consisting of a substitution and a deletion of a part or all of amino acids of the signal sequence and an addition of a new amino acid.
10 . A base sequence encoding the recombinant fusion protein of claim 1 .
11 . A vector for soluble expression of the recombinant fusion protein, the base sequence of claim 10 being introduced into the vector.
12 . A transformant for soluble expression of the recombinant fusion protein, the transformant being transformed with the vector of claim 11 .
13 . A method of purifying a recombinant fusion protein expressed in a soluble form, the method comprising:
a) expressing a recombinant fusion protein in a soluble form by transforming a non-human host cell with a vector into which a base sequence encoding a recombinant fusion protein is introduced, the recombinant fusion protein including: a target protein; and a ramp tag for controlling a translation speed, fused at an N-terminal of the target protein; and b) purifying the expressed recombinant fusion protein.
14 . The method of claim 13 , wherein b) includes:
b1) suspending the transformed cell and lysing and centrifuging the suspended cell to obtain a first supernatant; b2) shaking and then centrifuging a first mixture obtained by adding a first solvent to the first supernatant to obtain a second supernatant; and b3) shaking and then centrifuging a second mixture obtained by adding a second solvent to the second supernatant to recover the target protein.
15 . The method of claim 13 , wherein the target protein is hydrophobin.
16 . The method of claim 15 , wherein the target protein is Class I hydrophobin.
17 . The method of claim 16 , wherein the target protein is DewA.
18 . The method of claim 13 , wherein a wild type target protein consists of an amino acid sequence of SEQ ID NO: 2.
19 . The method of claim 13 , wherein the target protein consists of an amino acid sequence of SEQ ID NO: 8 or 10.
20 . The method of claim 13 , wherein the ramp tag is obtained by collecting a rare codon of the host cell.
21 . The method of claim 13 , wherein the host cell is a bacterium belonging to Escherichia sp., Salmonellae sp., Yersinia sp., Shigella sp., Enterobacter sp., Pseudomonas sp., Proteus sp., or Klebsiella sp.
22 . The method of claim 14 , wherein each of the first solvent and the second solvent is isopropyl alcohol.
23 . The method of claim 22 , wherein a volume ratio of the isopropyl alcohol to the first supernatant is 1:2 or 1:3.
24 . The method of claim 20 , wherein the ramp tag consists of an amino acid sequence of SEQ ID NO: 5.
25 . The method of claim 20 , wherein the rare codon is collected by analyzing a frequency of the codon and a number of isoacceptor tRNA genes.
26 . The method of claim 25 , wherein the frequency of the codon is 0.1 to 1%.
27 . The method of claim 24 , wherein the number of isoacceptor tRNA genes is 0 to 2.
28 . The method of claim 13 , wherein the target protein is a physiologically active protein including hormones and receptors thereof, biological response modifiers and receptors thereof, cytokines and receptors thereof, enzymes, antibodies, and antibody fragments.
29 . A recombinant fusion protein expressed in a soluble form, the recombinant fusion protein being purified by the method of claim 13 .Join the waitlist — get patent alerts
Track US2021363199A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.